Sonavex, Inc. — Form D/A
Sonavex, Inc. of BALTIMORE, MD, a company, filed a Form D amendment with the SEC on 2024-11-19. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-11-19
- Form: D/A
- Accession: 0001645892-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $15.0M
- Investors: 45
- Date of first sale: 2021-08-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-431825
Issuer
- Name: Sonavex, Inc.
- CIK: 0001645892
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 2835 O'DONNELL STREET SUITE 200, BALTIMORE, MD, 21224
- Phone: 443.862.2024
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Robert Hallenbeck | Director | Baltimore, MD |
| Michael J Hennessy, Jr. | Director | Baltimore, MD |
| David Narrow | Director | Baltimore, MD |
| Bill Niland | Director | Baltimore, MD |
| Devin O'Brien-Coon | Director | Baltimore, MD |
| Jerry Prince | Director | Baltimore, MD |
| David Narrow | Executive Officer | Baltimore, MD |
| Devin O'Brien-Coon | Executive Officer | Baltimore, MD |
| John Rappe | Executive Officer | Baltimore, MD |
| Evan Pritchard | Related Person | Baltimore, MD |
| David Narrow | Related Person | Baltimore, MD |
| Robert Hallenbeck | Related Person | Baltimore, MD |
| Devin O'Brien-Coon | Related Person | Baltimore, MD |
| William Niland | Related Person | Baltimore, MD |
| Bill L Niland | Director | Baltimore, MD |
| Jerry L Prince | Director | Baltimore, MD |
| Robert L Hallenbeck | Director | Baltimore, MD |
| Alex Yevzlin | Related Person | Baltimore, MD |
| Michael J. Hennessy, Jr. | Related Person | Baltimore, MD |
Other filings by this issuer (7)
More